Komori
Business alliance3417OHKI HEALTHCARE HOLDINGS CO.,LTD.Trading & Wholesale

Execution of a Memorandum of Understanding on a Business Alliance with Korea Ginseng Corporation

大木ヘルスケアホールディングス entered into a memorandum of understanding with Korea Ginseng Corporation to cooperate on product sales for Japan’s health and beauty market, joint planning and development, and joint research on ingredients.

Worth reading
49Recurring
Scored from 4 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Agreements reached under this partnership

Business alliance
3417OHKI HEALTHCARE HOLDINGS CO.,LTD.
Alliance partnerKorea Ginseng Corporation
Details of the alliance
  1. 1

    The Company will leverage its distribution network in Japan, including drugstores, for existing products held by KGC and products jointly developed by the two companies.

  2. 2

    The parties will jointly plan and develop differentiated products that meet consumer needs, targeting growth markets in Japan centered on femcare and inner beauty.

  3. 3

    The parties will establish a framework for considering joint research and regulatory approval applications in Japan for KGC’s high-value-added naturally derived ingredients, and explore their application to OTC medicines and related business opportunities.

These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.

About the partner
Business DescriptionResearch and development, cultivation management, manufacturing and processing, and domestic and international sales of health functional foods and beauty products centered on Korean ginseng (red ginseng)
LocationDaedeok-gu, Daejeon Metropolitan City, Republic of Korea
Share capitalKRW 71.85 billion (approximately ¥7.8 billion)
Agreements reached under this partnership
ItemDetails
Name of alliance partnerKorea Ginseng Corporation
Alliance partner's business activitiesResearch and development, cultivation management, manufacturing and processing, and domestic and international sales of health functional foods and beauty products centered on Korean ginseng (red ginseng)
Alliance partner's locationDaedeok-gu, Daejeon Metropolitan City, Republic of Korea
Alliance partner's capitalKRW 71.85 billion (approximately ¥7.8 billion)
Type of allianceBusiness alliance
Details of the allianceThe Company will leverage its distribution network in Japan, including drugstores, for existing products held by KGC and products jointly developed by the two companies., The parties will jointly plan and develop differentiated products that meet consumer needs, targeting growth markets in Japan centered on femcare and inner beauty., The parties will establish a framework for considering joint research and regulatory approval applications in Japan for KGC’s high-value-added naturally derived ingredients, and explore their application to OTC medicines and related business opportunities.
Items this document does not state (17)
Alliance partner's net salesAlliance partner's operating incomeNumber of shares acquiredAcquisition priceShareholding ratioOverview of the joint ventureOwnership ratioDispatch of directors and officersContract PeriodNumerical targets under the allianceShareholding PolicyDate of board resolutionContract DateAlliance start dateShare Acquisition Date and Payment DateImpact on Business PerformanceChange in major shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The parties will leverage their respective strengths to plan and develop differentiated products that meet consumer needs in Japan’s health and beauty market, while exploring business opportunities including the use in Japan of Korea Ginseng Corporation’s naturally derived ingredients and their application to OTC medicines.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Execution of a Memorandum of Understanding on a Business Alliance with Korea Ginseng Corporation | OHKI HEALTHCARE HOLDINGS CO.,LTD. (3417) timely disclosure | Komori